Bazbiomedic

What Bazbiomedic does

Bazbiomedic (legal name: BAZ BIOMEDIC CO., LTD.) is a privately held Korean medical device company headquartered in Gangnam-gu, Seoul, that develops and commercializes CUREJET, an automatic needle-free drug delivery device. The company's core technology uses ultra-fine-hole micro-injection at 150–500 m/s to deliver pharmaceutical preparations, plant extracts, vitamins, and other liquid substances through the skin without a needle, with controllable injection depth (0.25–2.50mm), up to 20 shots per second, and an asserted >90% immediate absorption rate. The technology originated from a Seoul National University research team and was commercialized under the CUREJET brand, positioned as the "world's first" needle-free device spanning both medical and aesthetic applications including medical aesthetic skin treatments, home beauty, insulin and hormone delivery, vaccines, and scalp/hair loss therapy.

The company holds Korean Medical Device Sales Business Registration (No. 2022-3220033-00688) and a Medical Device Manufacturing Permit (No. 7764), and operates an R&D center co-located at its Gangnam headquarters. Its go-to-market is built on direct business inquiries, a tri-lingual (Korean/English/Japanese) corporate website, and partnership outreach to cosmetics manufacturers, multinational pharmaceutical companies, and biomedical device firms; the only confirmed strategic partnership is a joint research agreement with S Bio Medics (Aug 2022) on cell secretome applications. Pricing is not publicly disclosed. The company has conducted multiple third-party share allocations from 2020 through 2024 and closed a Series B of approximately 10 billion KRW (~US$7.3M) in May 2024, with BNH Investment and Muirwoods Ventures named as investors, led by founder-CEO Prof. Yoh Jai-ick. Revenue, headcount, named customers, and international regulatory clearances beyond Korea are not disclosed in available data.

Name

Bazbiomedic

Legal name

BAZ BIOMEDIC CO.,LTD.

Website

https://bazbiomedic.com

Company type

Private

Founded year

2019

Operating status

Operating

Short description

Bazbiomedic is a privately held Seoul-based medical device company that develops and markets CUREJET, an automatic needle-free micro-injection drug delivery device used in medical aesthetic, pharmaceutical (insulin, hormones, vaccines), and scalp/hair treatment applications.

Ownership category

akta.pro rank

Product category

Medical Devices (Needle-Free Drug Delivery)

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Needle-Free Injection Systems (Jet Injectors/Microneedle Patches) (HLAHAIAD)

akta.pro secondary industries

Vaccine Delivery & Administration Systems (needle-free, microneedle patches, intranasal/oral) (HLAAAEAF), Skincare Devices (Cleansing Brushes, Microcurrent, LED, Dermaplaning) (CRABAKAI), Auto-Injectors (Disposable & Reusable) (HLAHAIAB)

Keywords

• Needle-free drug delivery
• Medical device manufacturing
• Aesthetic injection technology
• Micro-injection devices
• Dermal drug delivery

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Distribution channels2 records

Marketing channels3 records

Core offering

Bazbiomedic develops and manufactures CUREJET, an automatic needle-free drug delivery device that delivers pharmaceuticals, plant extracts, vitamins, and other liquid substances into facial or scalp skin through ultra-fine micro-injections at high speed (150–500 m/s) without damaging nerve cells. The device supports controllable injection depth (0.25–2.50 mm), up to 20 shots per second, and over 90% drug absorption, with applications spanning medical aesthetic treatments, insulin/hormone/vaccine delivery, and scalp and hair loss therapies. The company sells the device and its underlying micro-injection technology platform to enterprise customers including clinics, pharmaceutical companies, hair/scalp treatment providers, and cosmetic manufacturers.

Product overview

Bazbiomedic is a medical device company offering a single core product: CUREJET, an innovative automatic needle-free drug delivery device. The company specializes in micro-injection technology that delivers pharmaceutical preparations, plant extracts, vitamins, and other liquid substances through the skin without needles. The technology enables applications across medical aesthetic treatments, drug delivery (insulin, hormones, vaccines), and scalp/hair therapy. The company's proprietary technology achieves high absorption rates exceeding 90% through controlled injection depth and rapid consecutive shots.

Differentiator

Problem solved

Functional benefit

Brands

• CUREJET: Automatic needle-free injection drug delivery device developed by BAZ BIOMEDIC for medical and aesthetic applications including skin care, insulin delivery, hormone therapy, vaccines, and scalp/hair treatment.

Products and services

• CUREJET An automatic needle-free drug injection device that delivers pharmaceuticals, plant extracts, vitamins, and other liquid substances through ultra-fine holes at 150–500 m/s, with controllable injection depth (0.25–2.50 mm) and up to 20 shots per second. Supports medical aesthetic skin treatments, insulin delivery, hormone therapy, vaccines, and scalp/hair loss treatments, achieving over 90% drug absorption. Targeted at medical aesthetic clinics, dermatology practices, hair/scalp treatment providers, pharmaceutical companies, and cosmetic manufacturers.

Quantifiable outcome

• Over 90% drug absorption rate immediately after injection
• +4 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• S BIO MEDICS (에스바이오메딕스)coreStrategic or Co-development Partner · 18 August 2022Joint research contract for cell secretome research signed in August 2022. Collaboration between S Bio Medics and Bazbiomedic for developing advanced drug delivery applications using cell secretome technology.
• Cosmetics Manufacturers (Target Partners)minorOthersBazbiomedic is seeking partnerships with cosmetic manufacturers for integration of their needle-free drug delivery technology into cosmetic products.
• Multi-national Pharmaceutical Companies (Target Partners)minorOthersLooking to partner with multinational pharmaceutical companies for applications in insulin, hormone, and vaccine delivery using needle-free technology.
• Biomedical Device Companies (Target Partners)minorOthersSeeking collaboration with biomedical device companies specializing in liquid substance delivery for technology integration and co-development.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Regional players

• Classys: Korean manufacturer of aesthetic devices including HIFU and injection-assisted platforms. Regional comparable in the Korean medical aesthetics channel where CUREJET targets clinics.
• Jeisys Medical: Korean medical aesthetics device company offering energy-based and injection-related platforms. Regional peer that competes in the same Korean medical-aesthetic clinic channel where Bazbiomedic is initially commercializing CUREJET.

Emerging players

• DermapenWorld: Global microneedling device maker widely adopted in dermatology and aesthetic clinics. Emerging peer because microneedling is the primary non-jet alternative clinicians use for transdermal drug/active delivery, directly competing for the same clinic budgets.
• Inovio Pharmaceuticals: Developer of DNA vaccines and a CELLECTRA electroporation needle-free delivery device. Emerging peer that pursues needle-free administration of vaccines, partially overlapping with Bazbiomedic's vaccine use case.
• Enable Injections: Developer of large-volume wearable bolus injectors for biologics and viscous drugs. Emerging peer in the broader needle-replacing drug-delivery category that competes for the same pharma-partner mindshare.

Broad incumbents

• Sinclair Pharma: Aesthetic-specialty pharma company marketing injectable aesthetic products (hyaluronic acid, biostimulators). Broad incumbent because it sits in the same aesthetic injection clinic channel that Bazbiomedic targets with CUREJET, though via consumables rather than devices.
• Antares Pharma: Specialty pharma company focused on self-injection drug delivery devices including auto-injectors and pen injectors. Broad incumbent that competes in the same injection-device category, though its technology is needle-based rather than needle-free.

Direct peers

• Bioject Medical Technologies: Pioneer in needle-free jet injection technology (Biojector) for vaccine and therapeutic delivery. Closely comparable technology lineage and use cases (vaccines, biologics, dermatology) to Bazbiomedic's CUREJET.
• PharmaJet: US-based developer of needle-free jet injectors (Tropis, Stratis) used for vaccines and therapeutic delivery. Direct comparable because both companies commercialize needle-free jet-injection platforms targeting vaccine and drug-delivery applications.
• Portal Instruments: Developer of a needle-free jet injector platform originally partnered with MIT for biologics delivery (e.g., epinephrine, monoclonal antibodies). Direct peer in needle-free drug delivery technology with overlapping pharma-partnering strategy.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bazbiomedic